市場調査レポート

商品コード

細胞サイトメトリー市場：業界動向と世界の予測 - 細胞サイトメータータイプ別、企業規模別、地域別、主要企業

Cell Cytometry Market: Industry Trends and Global Forecasts - Distribution by Type of Cell Cytometer, Company Size and Geographical Regions and Leading Players

出版日: 2025年07月15日
発行: Roots Analysis
ページ情報: 英文 220 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,799 712,507円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (One-Location Site License)

USD 6,999 1,039,141円

レポートPDFを同一所在地における特定事業ユニットに属する全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Department License)

USD 10,599 1,573,633円

レポートPDFを部署単位で12名様までご利用いただけるライセンスです。同一部署内であれば、地理的に同じ地点に存在する必要はありません。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 17,999 2,672,311円

レポートPDFを同社の国内外拠点における全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.47円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の細胞サイトメトリー市場：概要

世界の細胞サイトメトリーの市場規模は、2035年までの予測期間中に10.1%のCAGRで拡大し、現在の18億2,000万米ドルから2035年までに52億6,000万米ドルに成長すると予測されています。

市場セグメンテーションでは、市場規模および機会分析を以下のパラメータで区分しています：

細胞サイトメータータイプ

ハイスループット型フローサイトメーター
イメージサイトメーター

企業規模

小規模
小規模
中規模
大規模
超大規模

地域

北米（米国、カナダ、メキシコ）
欧州（フランス、ドイツ、イタリア、スペイン、英国、その他）
アジア太平洋（中国、日本、インド、韓国、オーストラリア、ロシア、タイ、マレーシア、インドネシア、その他）
中東・北アフリカ（イラン、サウジアラビア、エジプト）
ラテンアメリカ（ブラジル、アルゼンチン、その他）

世界の細胞サイトメトリー市場：成長と動向

細胞サイトメトリーは、細胞の分析と特性解析に用いられる分析技術です。近年、この技術はヘルスケアおよび製薬業界で大きな支持を得ており、特にバイオマーカーの同定や薬力学と薬物動態の関係の評価に用いられています。さらに、免疫系に対する標的治療薬の効果を評価する際にも、セルサイトメーターは重要な役割を果たしています。最新のセルサイトメーターは、免疫細胞集団の詳細な特性解析と様々な疾患に対する反応を可能にし、生物学的サンプルを解析するための汎用性の高いツールとなっています。慢性疾患の世界の増加に伴い、細胞サイトメトリーのような高度な生物分析技術に対する需要は継続的に増加しています。

基礎研究から創薬、臨床診断に至るまで細胞サイトメトリーの応用範囲は広く、免疫反応の解明、疾病の進行追跡、細胞メカニズムの解明など、非常に貴重なツールとなっています。その結果、多くの業界関係者は、ハイスループット機能、多重化オプション、強化されたデータ解析ツールを特徴とする先進的な細胞サイトメトリー技術の開発に向けた研究活動に注力しています。

世界の細胞サイトメトリー市場：主要インサイト

当レポートでは、世界の細胞サイトメトリー市場の現状を掘り下げ、業界内の潜在的な成長機会を特定しています。当レポートの主な調査結果は以下の通りです。

現在、220を超えるセルサイトメーターが幅広い臨床研究および研究開発用途で使用可能であり、これらの大部分は米国企業により開発されています。
市場情勢は、複数の検出メカニズムとカラーチャンネルを利用して細胞をカウントし、選別する多様なセルサイトメーターを特徴としています。
10未満のカラーチャンネルを使用する高スループットフローサイトメーターの大部分（91％）は米国企業が開発しています。

競合優位性を構築するために、利害関係者はそれぞれのサイトメーターのポートフォリオに先進的な機能を組み込み、進化する業界ベンチマークに準拠しようと積極的に努力しています。
サイトメータの普及に伴い、複数の業界プレーヤーが高スループットフローサイトメータやイメージサイトメータに関して複数の契約を結んでいます。
前年の提携数は最大で、そのほとんどが販売契約と買収でした。
特筆すべきは、北米に本社を置く企業による買収です（75％）。
細胞サイトメトリー分野の機会に気づいたいくつかの投資家は、先進的な機能を備えたサイトメーターの開発を支援するために、総額数100万米ドルを投資しています。
ベンチャーラウンドによる調達額の大部分（～90％）は、ベンチャーシリーズBとDによって報告されており、このうちベンチャーシリーズBの資金調達ラウンドの事例がほとんどです。
産業界、非産業界を問わず、様々な世界イベントに参加し、細胞サイトメトリー業界の研究成果、関連課題、機会について議論しています。
この分野のウェビナーの75％はここ2、3年の間に開催されたもので、その大半はLabrootsが主催したものです。
セルサイトメーターに関連する特許は、過去5年間で1,500件以上が学界や産業界の利害関係者により取得／出願されており、その大半は特許出願です。
市場はCAGR 10.1%で成長すると予測されます。予測される市場機会は、さまざまなタイプのサイトメーターにうまく分配される可能性が高く、北米が現在の市場シェアの大半を獲得する可能性が高いです。

細胞サイトメトリー市場における参入企業例

Agilent
Beckton Dickinson
Beckman Coulter Life Sciences
Bio-Rad
Chemometec
Milkotronic
PerkinElmer
Sartorius
Sony Biotechnology
Thermo Fisher Scientific
Union Biometrica

世界の細胞サイトメトリー市場：主要セグメント

細胞サイトメータータイプ別では、市場はハイスループットセルサイトメーターとイメージサイトメーターに区分されます。現在、高スループットセルサイトメーターセグメントが世界の細胞サイトメトリー市場で最大（～60％）のシェアを占めています。しかし、細胞形態のサブセル可視化のための高解像度分析ツールに対する需要の高まりにより、イメージサイトメーターセグメントは予測期間中により高いCAGRで成長すると予想されます。

企業規模別では、市場は超小規模、小規模、中規模、大規模型、超規模企業に区分されます。現在、超大手セグメントは細胞サイトメトリー市場で最も高い割合（～40％）を占めています。さらに、このセグメントは、強力なR&D能力、広範な販売網、確立されたブランド評価に加え、この領域における大企業の継続的な取り組みにより、相対的に高いCAGRで成長する可能性が高いです。

主要地域別に見ると、市場は北米、欧州、アジア太平洋、その他の地域に区分されます。現在、北米（～60％）が細胞サイトメトリー市場を独占し、最大の収益シェアを占めています。しかし、アジア太平洋の市場は予測期間中に14%という高いCAGRで成長すると予測されています。

当レポートでは、世界の細胞サイトメトリー市場について調査し、市場の概要とともに、細胞サイトメータータイプ別、企業規模別動向、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

章の概要
主要な前提と調査手法
世界の細胞サイトメトリー市場（2035年まで）
- 世界の細胞サイトメトリー市場：細胞サイトメータータイプ別
- 世界の細胞サイトメトリー市場：企業規模別
- 世界の細胞サイトメトリー市場：主要地域別

第13章結論

第14章エグゼクティブ洞察

第15章付録1：表形式データ

第16章付録2：企業・団体一覧

図表

List of Tables

Table 4.1 High Throughput Flow Cytometers: Information on Type of High Throughput Flow Cytometer and Throughput Rate
Table 4.2 High Throughput Flow Cytometers: Information on Detection Rate
Table 4.3 High Throughput Flow Cytometers: Information on Type of Plate Format(s)
Table 4.4 High Throughput Flow Cytometers: Information on Number of Color Channels
Table 4.5 High Throughput Flow Cytometers: Information on Number of Detection Channels
Table 4.6 High Throughput Flow Cytometers: Information on Number of Laser Channels and Patented Technology
Table 4.7 High Throughput Flow Cytometers: Information on Availability of Automation, Availability of Automatic Sampling and Sample Volume
Table 4.8 High Throughput Flow Cytometers: Information on Type of Detection Mechanism(s)
Table 4.9 High Throughput Flow Cytometers: Information on Application(s)
Table 4.10 High Throughput Flow Cytometer Developers: Information on Year of Establishment, Company Size and Location of Headquarters
Table 6.1 Image Cytometer: Information on Type of Image Cytometer
Table 6.2 Image Cytometers: Information on Processing Time
Table 6.3 Image Cytometer: Information on Type of Plate Format(s) and Magnification
Table 6.4 Image Cytometer: Information on Output Format(s)
Table 6.5 Image Cytometer: Information on Sample Volume
Table 6.6 Image Cytometers: Information on Application(s)
Table 6.7 Image Cytometer Developers: Information on Year of Establishment, Company Size and Location of Headquarters
Table 8.1 List of Companies Profiled
Table 8.2 Agilent: Company Overview
Table 8.3 Agilent: Recent Developments and Future Outlook
Table 8.4 Beckman Coulter Life Sciences: Company Overview
Table 8.5 Beckman Coulter Life Sciences: Recent Developments and Future Outlook
Table 8.6 Becton Dickinson: Company Overview
Table 8.7 Becton Dickinson: Recent Developments and Future Outlook
Table 8.8 Bio-Rad: Company Overview
Table 8.9 Bio-Rad: Recent Developments and Future Outlook
Table 8.10 Chemometec: Company Overview
Table 8.11 Chemotec: Recent Developments and Future Outlook
Table 8.12 Milkotronic: Company Overview
Table 8.13 Nexcelom Bioscinces: Company Overview
Table 8.14 Sartorius: Company Overview
Table 8.15 Sartorius: Recent Developments and Future Outlook
Table 8.16 Sony Biotechnology: Company Overview
Table 8.17 Thermo Fischer Scientific: Company Overview
Table 8.18 Thermo Fischer Scientific: Recent Developments and Future Outlook
Table 8.19 Union Biometrica: Company Overview
Table 8.20 Union Biometrica: Recent Developments and Future Outlook
Table 9.1 Global Cell Cytometry: List of Partnerships and Collaborations, Since 2017
Table 10.1 Global Cell Cytometry: List of Funding and Investments, Since 2017
Table 10.2 Global Cell Cytometry: List of Global Events, Since 2018
Table 11.1 Patent Analysis: Prominent CPC Symbols
Table 11.2 Patent Analysis: List of Top CPC Symbols
Table 11.3 Patent Analysis: Most Popular CPC Symbols
Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 11.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 11.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 15.1 High Throughput Flow Cytometers: Distribution by Type of High Throughput Flow Cytometer
Table 15.2 High Throughput Flow Cytometers: Distribution by Throughput Rate
Table 15.3 High Throughput Flow Cytometers: Distribution by Detection Rate
Table 15.4 High Throughput Flow Cytometers: Distribution by Type of Plate Format(s)
Table 15.5 High Throughput Flow Cytometers: Distribution by Number of Color Channels
Table 15.6 High Throughput Flow Cytometers: Distribution by Number of Detection Channels
Table 15.7 High Throughput Flow Cytometers: Distribution by Number of Laser Channels
Table 15.8 High Throughput Flow Cytometers: Distribution by Sample Volume (in μl)
Table 15.9 High Throughput Flow Cytometers: Distribution by Type of Detection Mechanism(s)
Table 15.10 High Throughput Flow Cytometers: Distribution by Application(s)
Table 15.11 High Throughput Flow Cytometer Developers: Distribution by Year of Establishment
Table 15.12 High Throughput Flow Cytometer Developers: Distribution by Company Size
Table 15.13 High Throughput Flow Cytometer Developers: Distribution by Location of Headquarters
Table 15.14 Leading High Throughput Flow Cytometer Developers: Distribution by Number of Products Offered
Table 15.15 Image Cytometers: Distribution by Type of Image Cytometer
Table 15.16 Image Cytometers: Distribution by Processing Time
Table 15.17 Image Cytometers: Distribution by Type of Plate Format(s)
Table 15.18 Image Cytometers: Distribution by Output Format(s)
Table 15.19 Image Cytometers: Distribution by Sample Volume
Table 15.20 Image Cytometers: Distribution by Application(s)
Table 15.21 Image Cytometer Developers: Distribution by Year of Establishment
Table 15.22 Image Cytometer Developers: Distribution by Company Size
Table 15.23 Image Cytometer Developers: Distribution by Location of Headquarters
Table 15.24 Leading Image Cytometer Developers: Distribution by Number of Products Offered
Table 15.25 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2017
Table 15.26 Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.27 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2017
Table 15.28 Most Active Players: Distribution by Number of Partnerships
Table 15.29 Partnerships and Collaborations: Regional Analysis
Table 15.30 Partnerships and Collaborations: Local and International Agreements
Table 15.31 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 15.32 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, Since 2017
Table 15.33 Funding and Investment Analysis: Distribution by Type of Funding
Table 15.34 Funding and Investment Analysis: Cumulative Year-wise Distribution by Amount Invested, Since 2017 (USD Million)
Table 15.35 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Table 15.36 Funding and Investment Analysis: Year-Wise Distribution of Instances by Type of Funding and Total Amount Invested, Since 2017 (USD Million)
Table 15.37 Most Active Players: Distribution by Number of Funding Instances
Table 15.38 Most Active Players: Distribution by Amount Raised (USD Million)
Table 15.39 Most Active Investors: Distribution by Number of Funding Instances
Table 15.40 Global Events: Cumulative Half yearly Trend, Since 2018
Table 15.41 Global Events: Distribution by Event Platform
Table 15.42 Global Events: Distribution by Type of Event
Table 15.43 Global Events: Regional Distribution of Event
Table 15.44 Most Active Event Organizers: Distribution by Number of Events
Table 15.45 Most Active Organizations: Distribution by Number of Participants
Table 15.46 Patent Analysis: Distribution by Type of Patent
Table 15.47 Patent Analysis: Cumulative Distribution by Publication Year, Since 2020
Table 15.48 Patent Analysis: Cumulative Distribution by Annual Number of Granted Patents and Patent Applications, Since 2020
Table 15.49 Patent Analysis: Distribution by Geographical Location
Table 15.50 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, Since 2020
Table 15.51 Leading Industry Players: Distribution by Number of Patents
Table 15.52 Leading Non-Industry Players: Distribution by Number of Patents
Table 15.53 Leading Individual Assignees: Distribution by Number of Patents
Table 15.54 Leading Players: Benchmarking by Patent Characteristics (CPC Symbols)
Table 15.55 Patent Analysis: Year-wise Distribution of Patents by Age
Table 15.56 Cell Cytometry: Patent Valuation Analysis
Table 15.57 Global Cell Cytometry Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.58 Global Cell Cytometry Market: Distribution by Type of Cytometer
Table 15.59 Cell Cytometry Market for High Throughput Flow Cytometers, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.60 Cell Cytometry Market for Image Cytometers, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.61 Global Cell Cytometry Market: Distribution by Company Size
Table 15.62 Cell Cytometry Market for Very Small Companies, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.63 Cell Cytometry Market for Small Companies, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.64 Cell Cytometry Market for Mid-Sized Companies, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.65 Cell Cytometry Market for Large Companies, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.66 Cell Cytometry Market for Very Large Companies, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.67 Global Cell Cytometry Market: Distribution by Key Geographical Regions
Table 15.68 Cell Cytometry Market in North America, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.69 Cell Cytometry Market in Europe, Till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.70 Cell Cytometry Market in Asia-Pacific, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.71 Cell Cytometry Market in Rest of the World, Till 2035: Conservative, Base and Optimistic Scenarios (USD Million)

List of Figures

Figure 2.1 Executive Summary: High Throughput Flow Cytometers Market Landscape
Figure 2.2 Executive Summary: Image Cytometers Market Landscape
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Funding and Investment Analysis
Figure 2.5 Executive Summary: Global Events
Figure 2.6 Executive Summary: Patent Analysis
Figure 2.7 Executive Summary: Market Forecast
Figure 3.1 Types of Cytometers
Figure 3.2 Advantages of Different Types of Cytometry
Figure 3.3 Limitations of Different Types of Cytometry
Figure 3.4 Google Trends: Historical Timeline
Figure 3.5 Google Trends: Geographical Activity
Figure 4.1 High Throughput Flow Cytometers: Distribution by Type of High Throughput Flow Cytometer
Figure 4.2 High Throughput Flow Cytometers: Distribution by Throughput Rate
Figure 4.3 High Throughput Flow Cytometers: Distribution by Detection Rate
Figure 4.4 High Throughput Flow Cytometers: Distribution by Type of Plate Format(s)
Figure 4.5 High Throughput Flow Cytometers: Distribution by Number of Color Channels
Figure 4.6 High Throughput Flow Cytometers: Distribution by Number of DetectionChannels
Figure 4.7 High Throughput Flow Cytometers: Distribution by Number of LaserChannels
Figure 4.8 High Throughput Flow Cytometers: Distribution by Sample Volume (in μl)
Figure 4.9 High Throughput Flow Cytometers: Distribution by Type of Detection Mechanism(s)
Figure 4.10 High Throughput Flow Cytometers: Distribution by Application(s)
Figure 4.11 High Throughput Flow Cytometer Developers: Distribution by Year of Establishment
Figure 4.12 High Throughput Flow Cytometer Developers: Distribution by Company Size
Figure 4.13 High Throughput Flow Cytometer Developers: Distribution by Location of Headquarters
Figure 4.14 Leading High Throughput Flow Cytometer Developers: Distribution by Number of Products Offered
Figure 5.1 Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Players based in North America
Figure 5.2 Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Players based in Europe and Asia-Pacific
Figure 6.1 Image Cytometer: Distribution by Type of Image Cytometer
Figure 6.2 Image Cytometer: Distribution by Processing Time
Figure 6.3 Image Cytometer: Distribution by Type of Plate Format(s)
Figure 6.4 Image Cytometers: Distribution by Output Format(s)
Figure 6.5 Image Cytometers: Distribution by Sample Volume
Figure 6.6 Image Cytometer: Distribution by Application(s)
Figure 6.7 Image Cytometer Developers: Distribution by Year of Establishment
Figure 6.8 Image Cytometer Developers: Distribution by Company Size
Figure 6.9 Image Cytometer Developers: Distribution by Location of Headquarters
Figure 6.10 Leading Image Cytometer Developers: Distribution by Number of Products Offered
Figure 7.1 Product Competitiveness Analysis: Image Cytometers offered by Players based in North America
Figure 7.2 Product Competitiveness Analysis: Image Cytometers offered by Players based in Europe and Asia-Pacific
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2017
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2017
Figure 9.4 Most Active Players: Distribution by Number of Partnerships
Figure 9.5 Partnerships and Collaborations: Regional Analysis
Figure 9.6 Partnerships and Collaborations: Local and International Agreements
Figure 9.7 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, Since 2017
Figure 10.2 Funding and Investment Analysis: Distribution by Type of Funding
Figure 10.3 Funding and Investment Analysis: Cumulative Year-wise Distribution by Amount Invested, Since 2017 (USD Million)
Figure 10.4 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Figure 10.5 Funding and Investment Analysis: Year-Wise Distribution of Instances by Type of Funding and Total Amount Invested, Since 2017 (USD Million)
Figure 10.6 Most Active Players: Distribution by Number of Funding Instances
Figure 10.7 Most Active Players: Distribution by Amount Raised (USD Million)
Figure 10.8 Most Active Investors: Distribution by Number of Funding Instances
Figure 10.9 Global Events: Cumulative Half yearly Trend, Since 2018
Figure 10.10 Global Events: Distribution by Event Platform
Figure 10.11 Global Events: Distribution by Type of Event
Figure 10.12 Global Events: Regional Distribution of Events
Figure 10.13 Most Active Event Organizers: Distribution by Number of Events
Figure 10.14 Most Active Organizations: Distribution by Number of Participants
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Cumulative Distribution by Publication Year, Since 2020
Figure 11.3 Patent Analysis: Cumulative Distribution by Annual Number of Granted
Figure 11.4 Patent Analysis: Distribution by Geographical Location
Figure 11.5 Patent Analysis: Distribution by CPC Symbols
Figure 11.6 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, Since 2020
Figure 11.7 Leading Industry Players: Distribution by Number of Patents
Figure 11.8 Leading Non-Industry Players: Distribution by Number of Patents
Figure 11.9 Leading Individual Assignees: Distribution by Number of Patents
Figure 11.10 Leading Players: Benchmarking by Patent Characteristics (CPC Symbols)
Figure 11.11 Patent Analysis: Year-wise Distribution of Patents by Age
Figure 11.12 Cell Cytometry: Patent Valuation Analysis
Figure 12.1 Global Cell Cytometry Market, Till 2035 (USD Million)
Figure 12.2 Global Cell Cytometry Market: Distribution by Type of Cell Cytometer
Figure 12.3 Cell Cytometry Market for High Throughput Flow Cytometers, Till 2035 (USD Million)
Figure 12.4 Cell Cytometry Market for Image Cytometers, Till 2035 (USD Million)
Figure 12.5 Global Cell Cytometry Market: Distribution by Company Size
Figure 12.6 Cell Cytometry Market for Very Small Companies, Till 2035 (USD Million)
Figure 12.7 Cell Cytometry Market for Small Companies, Till 2035 (USD Million)
Figure 12.8 Cell Cytometry Market for Mid-sized Companies, Till 2035 (USD Million)
Figure 12.9 Cell Cytometry Market for Large Companies, Till 2035 (USD Million)
Figure 12.10 Cell Cytometry Market for Very Large Companies, Till 2035 (USD Million)
Figure 12.11 Global Cell Cytometry Market: Distribution by Key Geographical Regions
Figure 12.12 Cell Cytometry Market in North America, Till 2035 (USD Million)
Figure 12.13 Cell Cytometry Market in Europe, Till 2035 (USD Million)
Figure 12.14 Cell Cytometry Market in Asia-Pacific, Till 2035 (USD Million)
Figure 12.15 Cell Cytometry Market in Rest of the World, Till 2035 (USD Million)
Figure 13.1 Concluding Remarks: High Throughput Flow Cytometers Market Landscape
Figure 13.2 Concluding Remarks: Image Cytometers Market Landscape
Figure 13.3 Concluding Remarks: Partnerships and Collaborations
Figure 13.4 Concluding Remarks: Funding and Investment Analysis
Figure 13.5 Concluding Remarks: Global Events
Figure 13.6 Concluding Remarks: Patent Analysis
Figure 13.7 Concluding Remarks: Market Forecast

Product Code: RA100398

GLOBAL CELL CYTOMETRY MARKET: OVERVIEW

As per Roots Analysis, the global cell cytometry market is estimated to grow from USD 1.82 billion in the current year to USD 5.26 billion by 2035, at a CAGR of 10.1% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Cell Cytometer

High Throughput Flow Cytometers
Image Cytometers

Company Size

Very Small
Small
Mid-Sized
Large
Very Large

Geographical Regions

North America (US, Canada, Mexico)
Europe (France, Germany, Italy, Spain, UK, Rest of Europe)
Asia Pacific (China, Japan, India, South Korea, Australia, Russia, Thailand, Malaysia, Indonesia, Rest of Asia Pacific)
Middle East and North Africa (Iran, Saudi Arabia and Egypt)
Latin America (Brazil, Argentina, Rest of Latin America)

GLOBAL CELL CYTOMETRY MARKET: GROWTH AND TRENDS

Cell cytometry is an analytical technique used for the analysis and characterization of cells. Recently, this technique has gained significant traction within the healthcare and pharmaceutical industries, particularly for biomarker identification and for assessing the relationship between pharmacodynamics and pharmacokinetics. Additionally, cell cytometers play a crucial role in evaluating the effects of targeted therapies on the immune system. Modern cell cytometers enable detailed characterization of immune cell populations and their responses to various diseases, making them highly versatile tools for analyzing biological samples. With the global rise in chronic diseases, the demand for advanced bioanalytical techniques like cell cytometry is continuously increasing.

Given the wide applications of cell cytometry ranging from basic research to drug discovery and clinical diagnostics, it has become an invaluable tool for unraveling immune responses, tracking disease progression, and understanding cellular mechanisms. As a result, many industry players are focusing on research efforts to develop advanced cell cytometry technologies featuring high-throughput capabilities, multiplexing options and enhanced data analysis tools.

GLOBAL CELL CYTOMETRY MARKET: KEY INSIGHTS

The report delves into the current state of global cell cytometry market and identifies potential growth opportunities within industry. Some key findings from the report include:

Presently, over 220 cell cytometers are currently available for use across wide range of clinical studies and research applications; majority of these have been developed by companies based in the US.
The market landscape features a variety of cell cytometers that make use of multiple detection mechanisms and color channels to count and sort cells.
Majority (91%) of the high throughput flow cytometers that use less than 10 color channels have been developed by players headquartered in the US.

In pursuit of building a competitive edge, stakeholders are making an active effort to incorporate advanced features in their respective portfolio of cytometers and comply with evolving industry benchmarks.
With the growing adoption of cytometers, several industry players have signed multiple agreements for high throughput flow cytometers and image cytometers.
The maximum number of partnerships were reported in the previous year; most of these deals were distribution agreements and acquisitions.
Notably, all acquisitions in the industry have been undertaken by players headquartered in North America (75%); majority of these deals are focused on the expansion of product portfolio.
Having realized the opportunity in the cell cytometry segment, several investors have collectively invested multi-million dollars to aid the development of cytometers with advanced features.
Majority (~90%) of the amount raised via venture rounds was reported through venture series B and D; of these, most of the instances reported were of venture series B funding round.
Both industry and non-industry players have participated in various global events to discuss the research outcomes, affiliated challenges as well as opportunities in the cell cytometry industry.
75% of the webinars in this domain have been organized in the last couple of years; of these, majority were organized by Labroots.
More than 1,500 patents related to cell cytometers have been granted / filed by academia and industry stakeholders in the last five years; majority of these were patent applications.
The market is expected to grow at a CAGR of 10.1%; the projected market opportunity is likely to be well distributed across different types of cytometers; North America is likely to capture majority of the current market share.

Example Players in the Cell Cytometry Market

Agilent
Beckton Dickinson
Beckman Coulter Life Sciences
Bio-Rad
Chemometec
Milkotronic
PerkinElmer
Sartorius
Sony Biotechnology
Thermo Fisher Scientific
Union Biometrica

GLOBAL CELL CYTOMETRY MARKET: KEY SEGMENTS

High Throughput Cell Cytometers Segment Occupies the Largest Share of the Cell Cytometry Market

Based on the type of cell cytometers, the market is segmented into high throughput cell cytometers and image cytometers. At present, high throughput cell cytometers segment holds the maximum (~60%) share of the global cell cytometry market. However, due to the rising demand for high resolution analytical tools for the sub-cellular visualization of cell morphology, image cytometers segment is expected to grow at a higher CAGR during the forecast period.

By Company Size, Very Large Companies is the Fastest Growing Segment of the Global Cell Cytometry Market

Based on the company size, the market is segmented into very small, small, mid-size, large, and very large companies. Currently, very large segment captures the highest proportion (~40%) of the cell cytometry market. Further, this segment is likely to grow at a relatively higher CAGR due to the ongoing efforts of large companies in this domain, in addition to their strong R&D capabilities, extensive distribution networks and established brand reputation.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Currently, North America (~60%) dominates the cell cytometry market and accounts for the largest revenue share. However, the market in Asia-Pacific is expected to grow at a higher CAGR of 14% during the forecast period.

GLOBAL CELL CYTOMETRY MARKET

Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global cell cytometry market, focusing on key market segments, including [A] type of cell cytometer, [B] company size and [C] key geographical regions.
High Throughput Flow Cytometers Market Landscape: A comprehensive evaluation of high throughput flow cytometers, considering various parameters, such as [A] type of high throughput flow cytometer, [B] throughput rate (wells per minute), [C] detection rate, [D] type of plate format(s), [E] number of color channels, [F] number of laser channels, [G] number of detection channels, [H] sample volume (in µl), [I] type of detection mechanism(s) and [J] application(s). Additionally, the section presents a comprehensive evaluation of high throughput flow cytometer developers, based on [A] year of establishment, [B] company size, [C] location of headquarters and [D] leading players.
Product Competitiveness Analysis: An insightful competitive analysis of high throughput flow cytometers, examining factors, such as [A] developer power and [B] product competitiveness.
Image Cytometers Market Landscape: A comprehensive evaluation of image cytometers, considering various parameters, such as [A] type of image cytometer, [B] processing time, [C] type of plate format(s), [D] output format(s), [E] sample volume and [F] application(s). Additionally, a comprehensive evaluation of image cytometer developers, based on [A] year of establishment, [B] company size, [C] location of headquarters and [E] leading players (in terms of number of products being offered).
Product Competitiveness Analysis: An insightful competitive analysis of image cytometers, examining factors, such as [A] developer power and [B] product competitiveness.
Company Profiles: In-depth profiles of companies engaged in the development / commercialization of cell cytometers, focusing on [A] company overview and [B] recent developments and an informed future outlook.
Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in this domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] most active players (in terms of the number of partnerships signed) and [D] geographical distribution of partnership activity.
Recent Developments: A detailed analysis of recent developments / trends related to global cell cytometry domain, providing key insights on the funding activity in this domain, based on several relevant parameters, such as [A] year of funding, [B] type of funding, [C] amount invested (USD Million), [D] most active players and [E] most active investors. Additionally, the section presents a detailed evaluation of the global events attended by the participants, based on several relevant parameters, such as [A] year of event, [B] event platform, [C] type of event, [D] most active organizers and [E] most active organizations.
Patent Analysis: An in-depth analysis of patents filed / granted for cell cytometry, based on various relevant parameters, such as [A] publication year, [B] geography, [C] CPC symbols, [D] emerging focus areas, [E] type of applicant, [F] leading industry players and [G] patent valuation analysis.

KEY QUESTIONS ANSWERED IN THIS REPORT

How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
15% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older

1. PREFACE

1.1. Scope of the Report
1.2. Research Methodology
- 1.2.1. Research Assumptions
- 1.2.2. Project Methodology
- 1.2.3. Forecast Methodology
- 1.2.4. Robust Quality Control
- 1.2.5. Key Considerations
  - 1.2.5.1. Demographics
  - 1.2.5.2. Economic Factors
  - 1.2.5.3. Government Regulations
  - 1.2.5.4. Supply Chain
  - 1.2.5.5. COVID Impact / Related Factors
  - 1.2.5.6. Market Access
  - 1.2.5.7. Healthcare Policies
  - 1.2.5.8. Industry Consolidation
1.3 Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. Cell Cytometry
- 3.2.1. Flow Cytometry
  - 3.2.1.1. High Throughput Flow Cytometry
- 3.2.2 Image Cytometry
3.3. Advantages and Limitations of Cell Cytometry
3.4. Prevalent Trends Related to Cell Cytometry
- 3.4.1. Key Historical Trends
- 3.4.2. Geographical Activity

4. HIGH THROUGHPUT FLOW CYTOMETERS: MARKET LANDSCAPE

4.1. Chapter Overview
4.2. High Throughput Flow Cytometers: Overall Market Landscape
- 4.2.1. Analysis by Type of High Throughput Flow Cytometer
- 4.2.2. Analysis by Throughput Rate
- 4.2.3. Analysis by Detection Rate
- 4.2.4. Analysis by Type of Plate Format(s)
- 4.2.5. Analysis by Number of Color Channels
- 4.2.6. Analysis by Number of Detection Channels
- 4.2.7. Analysis by Number of Laser Channels
- 4.2.8. Analysis by Sample Volume
- 4.2.9. Analysis by Type of Detection Mechanism(s)
- 4.2.10. Analysis by Application(s)
4.3. High Throughput Flow Cytometers: Developer Landscape
- 4.3.1. Analysis by Year of Establishment
- 4.3.2. Analysis by Company Size
- 4.3.3. Analysis by Location of Headquarters
- 4.3.4. Most Active Players: Analysis by Number of Products Offered

5. PRODUCT COMPETITIVENESS ANALYSIS: HIGH THROUGHPUT FLOW CYTOMETERS

5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Product Competitiveness Analysis
- 5.4.1. Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Developers based in North America
- 5.4.2. Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Developers based in Europe and Asia-Pacific

6. IMAGE CYTOMETERS: MARKET LANDSCAPE

6.1. Chapter Overview
6.2. Image Cytometers: Overall Market Landscape
- 6.2.1. Analysis by Type of Image Cytometer
- 6.2.2. Analysis by Processing Time
- 6.2.3. Analysis by Type of Plate Format(s)
- 6.2.4. Analysis by Output Format(s)
- 6.2.5. Analysis by Sample Volume
- 6.2.6. Analysis by Application(s)
6.3. Image Cytometers: Developer Landscape
- 6.3.1. Analysis by Year of Establishment
- 6.3.2. Analysis by Company Size
- 6.3.3. Analysis by Location of Headquarters
- 6.3.4. Most Active Players: Analysis by Number of Products Offered

7. PRODUCT COMPETITIVENESS ANALYSIS: IMAGE CYTOMETERS

7.1. Chapter Overview
7.2. Assumptions / Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis
- 7.4.1. Product Competitiveness Analysis: Image Cytometers offered by Developers based in North America
- 7.4.2. Product Competitiveness Analysis: Image Cytometers offered by Developers based in Europe and Asia-Pacific

8. GLOBAL CELL CYTOMETRY: COMPANY PROFILES

8.1. Chapter Overview
8.2. Agilent
- 8.2.1. Company Overview
- 8.2.2. Recent Developments and Future Outlook
8.3. Beckman Coulter Life Sciences
- 8.3.1. Company Overview
- 8.3.2. Recent Developments and Future Outlook
8.4. Becton Dickinson
- 8.4.1. Company Overview
- 8.4.2. Recent Developments and Future Outlook
8.5. Bio-Rad
- 8.5.1. Company Overview
- 8.5.2. Recent Developments and Future Outlook
8.6. Chemometec
- 8.6.1. Company Overview
- 8.6.2. Recent Developments and Future Outlook
8.7. Milkotronic
- 8.7.1. Company Overview
- 8.7.2. Recent Developments and Future Outlook
8.8. Nexcelom Bioscience
- 8.8.1. Company Overview
- 8.8.2. Recent Developments and Future Outlook
8.9. Sartorius
- 8.9.1. Company Overview
- 8.9.2. Recent Developments and Future Outlook
8.10. Sony Biotechnology
- 8.10.1. Company Overview
- 8.10.2. Recent Developments and Future Outlook
8.11. ThermoFisher Scientific
- 8.11.1. Company Overview
- 8.11.2. Recent Developments and Future Outlook
8.12. Union Biometrica
- 8.12.1. Company Overview
- 8.12.2. Recent Developments and Future Outlook

9. GLOBAL CELL CYTOMETYRY: PARTNERSHIPS AND COLLABORATIONS

9.1. Chapter Overview
9.2. Partnership Models
9.3. List of Partnerships and Collaborations
- 9.3.1. Analysis by Year of Partnership
- 9.3.2. Analysis by Type of Partnership
- 9.3.3. Most Active Players: Analysis by Number of Partnerships
- 9.3.4. Regional Analysis
- 9.3.5. Intercontinental and Intracontinental Agreements

10. RECENT DEVELOPMENTS

10.1. Chapter Overview
10.2. Global Cell Cytometry: Funding and Investment Analysis
- 10.2.1. Types of Funding
- 10.2.2. Analysis by Year of Investment
- 10.2.3. Analysis by Type of Funding
- 10.2.4. Analysis by Amount Invested
- 10.2.5. Most Active Players: Analysis by Number of Funding Instances
- 10.2.6. Most Active Players: Analysis by Amount Raised
- 10.2.7. Most Active Investors: Analysis by Number of Funding Instances
10.3. Global Cell Cytometry: Global Event Analysis
- 10.3.1. Analysis by Year of Event
- 10.3.2. Analysis by Event Platform
- 10.3.3. Analysis by Type of Event
- 10.3.4. Analysis by Geography
- 10.3.5. Most Active Event Organizers: Analysis by Number of Events
- 10.3.6. Most Active Organizations: Analysis by Number of Participants
10.4. Concluding Remarks

11. PATENT ANALYSIS

11.1. Chapter Overview
11.2. Scope and Methodology
- 11.2.1. Analysis by Type of Patent
- 11.2.2. Analysis by Patent Publication Year
- 11.2.3. Analysis by Annual Number of Granted Patents and Patent Applications
- 11.2.4. Analysis by Geographical Location
- 11.2.5. Analysis by CPC Symbols
- 11.2.6. Analysis by Type of Organization
- 11.2.7. Leading Industry Players: Analysis by Number of Patents
- 11.2.8. Leading Non-Industry Players: Analysis by Number of Patents
- 11.2.9. Leading Individual Assignees: Analysis by Number of Patents
11.3. Cell Cytometry: Patent Benchmarking Analysis
- 11.3.1. Analysis by Patent Characteristics
11.4. Cell Cytometry: Patent Valuation Analysis
11.5. Leading Patents by Number of Citations

12. MARKET FORECAST

12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Cell Cytometry Market, Till 2035
- 12.3.1. Global Cell Cytometry Market: Distribution by Type of Cell Cytometer
  - 12.3.1.1. Cell Cytometry Market for High Throughput Flow Cytometers, Till 2035
  - 12.3.1.2. Cell Cytometry Market for Image Cytometers, Till 2035
- 12.3.2. Global Cell Cytometry Market: Distribution by Company Size
  - 12.3.2.1. Cell Cytometry Market for Very Small Companies, Till 2035
  - 12.3.2.2. Cell Cytometry Market for Small Companies, Till 2035
  - 12.3.2.3. Cell Cytometry Market for Mid-sized Companies, Till 2035
  - 12.3.2.4. Cell Cytometry Market for Large Companies, Till 2035
  - 12.3.2.5. Cell Cytometry Market for Very Large Companies, Till 2035
- 12.3.3. Global Cell Cytometry Market: Distribution by Key Geographical Regions
  - 12.3.3.1. Cell Cytometry Market in North America, Till 2035
  - 12.3.3.2. Cell Cytometry Market in Europe, Till 2035
  - 12.3.3.3. Cell Cytometry Market in Asia-Pacific, Till 2035
  - 12.3.3.4. Cell Cytometry Market in Rest of the World, Till 2035

細胞サイトメトリー市場：業界動向と世界の予測 - 細胞サイトメータータイプ別、企業規模別、地域別、主要企業

Cell Cytometry Market: Industry Trends and Global Forecasts - Distribution by Type of Cell Cytometer, Company Size and Geographical Regions and Leading Players

世界の細胞サイトメトリー市場：概要

世界の細胞サイトメトリー市場：成長と動向

世界の細胞サイトメトリー市場：主要インサイト

細胞サイトメトリー市場における参入企業例

世界の細胞サイトメトリー市場：主要セグメント

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 イントロダクション

第4章 ハイスループットフローサイトメーター：市場情勢

第5章 製品競争力分析：ハイスループットフローサイトメーター

第6章 イメージサイトメーター：市場情勢

第7章 製品競争力分析：イメージサイトメーター

第8章 世界細胞サイトメトリー：企業プロファイル

第9章 世界細胞計測：パートナーシップと協力

第10章 最近の動向

第11章 特許分析

第12章 市場予測

第13章 結論

第14章 エグゼクティブ洞察

第15章 付録1：表形式データ

第16章 付録2：企業・団体一覧

List of Tables

List of Figures

GLOBAL CELL CYTOMETRY MARKET: OVERVIEW

GLOBAL CELL CYTOMETRY MARKET: GROWTH AND TRENDS

GLOBAL CELL CYTOMETRY MARKET: KEY INSIGHTS

Example Players in the Cell Cytometry Market

GLOBAL CELL CYTOMETRY MARKET: KEY SEGMENTS

GLOBAL CELL CYTOMETRY MARKET

KEY QUESTIONS ANSWERED IN THIS REPORT

REASONS TO BUY THIS REPORT

ADDITIONAL BENEFITS

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. HIGH THROUGHPUT FLOW CYTOMETERS: MARKET LANDSCAPE

5. PRODUCT COMPETITIVENESS ANALYSIS: HIGH THROUGHPUT FLOW CYTOMETERS

6. IMAGE CYTOMETERS: MARKET LANDSCAPE

7. PRODUCT COMPETITIVENESS ANALYSIS: IMAGE CYTOMETERS

8. GLOBAL CELL CYTOMETRY: COMPANY PROFILES

9. GLOBAL CELL CYTOMETYRY: PARTNERSHIPS AND COLLABORATIONS

10. RECENT DEVELOPMENTS

11. PATENT ANALYSIS

12. MARKET FORECAST

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

第1章序文

第2章エグゼクティブサマリー

第3章イントロダクション

第4章ハイスループットフローサイトメーター：市場情勢

第5章製品競争力分析：ハイスループットフローサイトメーター

第6章イメージサイトメーター：市場情勢

第7章製品競争力分析：イメージサイトメーター

第8章世界細胞サイトメトリー：企業プロファイル

第9章世界細胞計測：パートナーシップと協力

第10章最近の動向

第11章特許分析

第12章市場予測

第13章結論

第14章エグゼクティブ洞察

第15章付録1：表形式データ

第16章付録2：企業・団体一覧